The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1

Virology

Volumn 237, Issue 1, 1997, Pages 159-169

  Kanaya, Taro ^a   Kyo, Satoru ^b   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING SITE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENHANCER REGION; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; VIRUS EXPRESSION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0030680303     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8771     Document Type: Article

References (48)

1. Apt D., Chong T., Liu Y., Bernard H.-U. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol. 67:1993;4455-4463.
2. Apt D., Liu Y., Bernard H.-U. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: Interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res. 22:1994;3825-3833.
3. Apt D., Watts R. M., Suske G., Bernard H.-U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 224:1996;281-291.
4. Barbosa M. S., Edmonds C., Fisher C., Schiller J. T., Lowy D. R., Vousden K. H. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9:1990;153-160.
5. Bauknecht T., Angel P., Royer H.-D., zur Hauzen H. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: Interaction with the transcriptional repressor YY1. EMBO J. 11:1992;4607-4617.
6. Bauknecht T., Jundt F., Herr I., Oehler T., Delius H., Shi Y., Angel P., zur Hauzen H. A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter. J. Virol. 69:1995;1-12.
7. Bauknecht T., See R. H., Shi Y. A novel C/EBP β-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J. Virol. 70:1996;7695-7705.
8. Bedell M. A., Jones K. H., Grossman S. R., Laimins L. A. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J. Virol. 63:1989;1247-1255.
9. Bedell M. A., Hudson J. B., Golub T. R., Turyk M. E., Hosken M., Wilbanks G. D., Laimins L. A. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:1991;2254-2260.
10. Chan W.-K., Chong T., Bernard H.-U., Klock G. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res. 18:1990;763-769.
11. Chin M. T., Broker T. R., Chow L. T. Identification of a novel constitutive enhancer element and an associated binding protein: Implications for human papillomavirus type 11 enhancer regulation. J. Virol. 63:1989;2967-2976.
12. Cripe T. P., Haugen T. H., Turk J. P., Tabatabai F., Schmid P. G., Dürst M., Gissmann L., Roman A., Turek L. P. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: Implications for cervical carcinogenesis. EMBO J. 6:1987;3745-3753.
13. DelVacchio A. M., Romanczuk H., Howley P. M., Baker C. C. Transient replication of human papillomavirus DNAs. J. Virol. 66:1992;5949-5958.
14. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
15. Dong X.-P., Stubenrauch F., Beyer-Finkler E., Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV16 DNA from cervical cancers. Int. J. Cancer. 58:1994;803-808.
16. Dyson N., Howley P. M., Münger K., Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
17. Gius D., Grossman S., Bedell M. A., Laimins L. A. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18. J. Virol. 62:1988;665-672.
18. Gloss B., Bernard H.-U., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6:1987;3735-3743.
19. Goldsborough M. D., DiSilvestre D., Temple G. F., Lorincz A. T. Nucleotide sequence of human papillomavirus type 31: A cervical neoplasia-associated virus. Virology. 171:1989;306-311.
20. Higuchi R., Krummel B., Saiki R. K. A general method in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucleic Acids Res. 16:1988;7351-7367.
21. Hyde-DeRuyscher R. P., Jennings E., Shenk T. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res. 23:1995;4457-4465.
22. Ishiji T., Lace M. J., Parkkinen S., Anderson R. D., Haugen T. H., Cripe T. P., Xiao J.-H., Davidson I., Chambon P., Turek L. P. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J. 11:1992;2271-2281.
23. Kenndy I. M., Haddow J. K., Clements J. B. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65:1991;2093-2097.
24. Kyo S., Inoue M., Nishio Y., Nakanishi K., Akira S., Inoue H., Yutsudo M., Tanizawa O., Hakura A. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J. Virol. 67:1993;1058-1066.
25. Kyo S., Tam A., Laimins L. A. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology. 211:1995;184-197.
26. Kyo S., Klumpp D. J., Inoue M., Kanaya T., Laimins L. A. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J. Gen. Virol. 78:1997;401-411.
27. Lorincz A. T., Lancaster W. D., Temple G. F. Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J. Virol. 58:1986;225-229.
28. Mack D. H., Laimins L. A. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;9102-9106.
29. Macnab J. C. M., Walkinshaw S. A., Cordiner J. W., Clements J. B. Human Papillomavirus in clinically and historogically normal tissue of patients with genital cancer. N. Engl. J. Med. 315:1986;1052-1058.
30. Matlashewski G., Schneider J., Banks L., Jones N., Murray A., Crawford L. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6:1987;1741-1746.
31. May M., Dong X.-P., Beyer-Finkler E., Stubenrauch F., Fuchs P. G., Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 13:1994;1460-1466.
32. McCance D. J., Kopan R., Fuchs E., Laimins L. A. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;7169-7173.
33. O'Connor M., Chan S.-Y., Bernard H.-U. Transcription factor binding sites in the long control region of genital HPVs. Human Papillomavirus. 1995a;Los Alamos National Laboratory, Los Alamos. p. 21-40.
34. O'Connor M., Bernard H.-U. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology. 207:1995b;77-88.
35. O'Connor M., Tan S.-H., Tan C.-H., Bernard H.-U. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol. 70:1996;6529-6539.
36. Pfister H. Human papillomaviruses and genital cancer. Adv. Cancer Res. 48:1987;113-147.
37. Pheleps W. C., Yee C. L., Münger K., Howley P. M. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 53:1988;539-547.
38. Rader J. S., Golub T. R., Hudson J. B., Patel D., Bedell M. A., Laimins L. A. In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. Oncogene. 5:1990;571-576.
39. Rheinwald J. G., Beckett M. A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41:1981;1657-1663.
40. Roman A., Brown D. Sequence variation in the extreme 5′ end of the human papillomavirus type 6a long control region. J. Infect. Dis. 171:1995;697-700.
41. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encode by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
42. Shi Y., Seto E., Chang L.-S., Shenk T. Transcriptional repression by YY1, a Human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 67:1991;377-388.
43. Tan S.-H., Leong L. E.-C., Walker P. A., Bernard H.-U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Spl and TFIID. J. Virol. 68:1994;6411-6420.
44. Thierry F., Heard J. M., Dartmann K., Yaniv M. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J. Virol. 61:1987;134-142.
45. van Ranst M., Tachezy R., Burk R. D. Human papillomaviruses: A neverending story? Lacey C. Papillomavirus Reviews: Current Research on Papillomaviruses. 1996;1-19 Leeds Univ. Press, London.
46. Watanabe S., Kanda T., Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol. 63:1989;965-969.
47. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
48. Yant S. R., Zhu W., Millinoff D., Slightom J. L., Goodman M., Gumucio D. L. High affinity YY1 binding motifs: Identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human β globin cluster. Nucleic Acid Res. 23:1995;4353-4362.